1. EachPod

Heart Matters - Podcast

Heart Matters

Since cardiovascular disease is one of the leading causes of death in the U.S., cardiology physicians are continuously working to better understand this common disease and to help patients improve their heart health. And here to assist cardiology physicians in this mission is Heart Matters, a series dedicated to covering essential strategies and research efforts focusing on all types of heart problems, including coronary artery diseases, heart attacks, high cholesterol, high blood pressure, and more.
So whether you’re looking for ways to improve heart health or catch up on the latest cardiology research, you never have to worry about missing a beat thanks to Heart Matters.

Science & Medicine Medicine Health
Update frequency
every 14 days
Episodes
374
Years Active
2008 - 2025
Share to:
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers

Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers

Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Host: Rishi Wadhera, MD, MPP, Mphil

This on-demand knowledge primer explores key challenges and evidence-based strategies for improving …

Thu 03 Apr 2025
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers

Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers

Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Host: Rishi Wadhera, MD, MPP, Mphil

This on-demand knowledge primer explores key challenges and evidence-based strategies for improving …

Thu 03 Apr 2025
LDL-C Management Trends in ASCVD Patients

LDL-C Management Trends in ASCVD Patients

Host: Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA

A concerning number of patients with atherosclerotic cardiovascular disease (ASCVD) reached suboptimal LDL-C levels between 202…

Fri 20 Dec 2024
LDL-C Management Trends in ASCVD Patients

LDL-C Management Trends in ASCVD Patients

Host: Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA

A concerning number of patients with atherosclerotic cardiovascular disease (ASCVD) reached suboptimal LDL-C levels between 202…

Fri 20 Dec 2024
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)

Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)

Host: John Russell, MD
Guest: Noel Dasgupta, MD, FACC
Guest: Sami Khella, MD

Amyloidosis, often unrecognized, misdiagnosed, and either inappropriately treated or undertreated, is a …

Fri 13 Dec 2024
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)

Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)

Host: John Russell, MD
Guest: Noel Dasgupta, MD, FACC
Guest: Sami Khella, MD

Amyloidosis, often unrecognized, misdiagnosed, and either inappropriately treated or undertreated, is a …

Fri 13 Dec 2024
Phase 3 study results of plozasiran in patients with FCS

Phase 3 study results of plozasiran in patients with FCS

Host: Gerald Watts, MD, PhD

There is a high unmet need for patients with persistent chylomicronemia. Plozasiran (ARO-APOC3) is an investigational drug that is being evaluated for these pati…

Tue 24 Sep 2024
Phase 3 study results of plozasiran in patients with FCS

Phase 3 study results of plozasiran in patients with FCS

Host: Gerald Watts, MD, PhD

There is a high unmet need for patients with persistent chylomicronemia. Plozasiran (ARO-APOC3) is an investigational drug that is being evaluated for these pati…

Tue 24 Sep 2024
How Artificial Sweeteners Could Be Linked to Heart Disease

How Artificial Sweeteners Could Be Linked to Heart Disease

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Wilson Tang, MD

Many different artificial sweeteners are being consumed by patients; however, this discussion will focus on …

Tue 11 Jun 2024
How Artificial Sweeteners Could Be Linked to Heart Disease

How Artificial Sweeteners Could Be Linked to Heart Disease

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Wilson Tang, MD

Many different artificial sweeteners are being consumed by patients; however, this discussion will focus on …

Tue 11 Jun 2024
Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link

Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link

Host: Javed Butler, MD
Guest: Jeffrey Wilson, MD

There’s a decent amount of evidence showing allergic immune responses could have connections with heart disease. But with the knowledge …

Tue 19 Mar 2024
Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link

Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link

Host: Javed Butler, MD
Guest: Jeffrey Wilson, MD

There’s a decent amount of evidence showing allergic immune responses could have connections with heart disease. But with the knowledge …

Tue 19 Mar 2024
Active Aging: Preventing Heart Failure in Older Women with Exercise

Active Aging: Preventing Heart Failure in Older Women with Exercise

Host: Javed Butler, MD
Guest: Michael J. LaMonte, PhD, MPH

The American Heart Association recommends physical activity to help lower the risk of heart failure, but how much exercise is …

Tue 19 Mar 2024
Active Aging: Preventing Heart Failure in Older Women with Exercise

Active Aging: Preventing Heart Failure in Older Women with Exercise

Host: Javed Butler, MD
Guest: Michael J. LaMonte, PhD, MPH

The American Heart Association recommends physical activity to help lower the risk of heart failure, but how much exercise is …

Tue 19 Mar 2024
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD

AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD

Host: Javed Butler, MD
Guest: Chiadi Ndumele, M.D., Ph.D., M.H.S.

For the first time, the American Heart Association (AHA) has identified cardiovascular-kidney-metabolic (CKM) syndrome,…

Tue 16 Jan 2024
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD

AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD

Host: Javed Butler, MD
Guest: Chiadi Ndumele, M.D., Ph.D., M.H.S.

For the first time, the American Heart Association (AHA) has identified cardiovascular-kidney-metabolic (CKM) syndrome,…

Tue 16 Jan 2024
Pharmacist-Prescribing and Hypertension Management: An Economic Benefit

Pharmacist-Prescribing and Hypertension Management: An Economic Benefit

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Dave L. Dixon, PharmD, FACC,  FCCP, FNLA, BCPS, BCACP, CDE, CLS

What would the cost-effectiveness look like if the uptake of…

Tue 12 Dec 2023
Pharmacist-Prescribing and Hypertension Management: An Economic Benefit

Pharmacist-Prescribing and Hypertension Management: An Economic Benefit

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Dave L. Dixon, PharmD, FACC,  FCCP, FNLA, BCPS, BCACP, CDE, CLS

What would the cost-effectiveness look like if the uptake of…

Tue 12 Dec 2023
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity

Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Javed Butler, MD

There’s no approved therapies specifically targeting obesity and HFpEF, but based on the STEP-HFpEF study t…

Fri 22 Sep 2023
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity

Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Javed Butler, MD

There’s no approved therapies specifically targeting obesity and HFpEF, but based on the STEP-HFpEF study t…

Fri 22 Sep 2023
Disclaimer: The podcast and artwork embedded on this page are the property of ReachMD. This content is not affiliated with or endorsed by eachpod.com.